Friday, July 1, 2022 Daily Archives

Maximizing Performance of Your Biologics Pipeline: Media and Process Optimization Using Cutting-Edge Tools

by

This webcast features: Yaron Silberberg, PhD, Chief Scientist, Ajinomoto Genexine. Cell culture media composition and upstream bioprocess conditions are crucial factors affecting productivity in the production of biotherapeutics. In recent years, advanced techniques using IT approaches, including computer simulation of bioprocesses, AI and multi-omics methods for analysis of cellular metabolic pathways, allow optimization of both process and media composition for maximizing protein production and process productivity. In this webinar, a quick overview of biologics production and the importance of cell…

July 1, 2022

IVT Network Podcast Archive

by

Journal of Validation Technology 2022  The EU GMP Annex1 Revision 2022 Implementation Laboratory Review Process and Its Impact on Compliance Data Integrity and Integrating Automation Risk Revolution: ICH Q9 Revision, Is it Enough? The Quality Control Response to COVID Disruption in Labs  The New Norm for Life Sciences Talent Evolution 2021 Paper Versus Electronic Records Ruggedness of Visible Residue Limits for Cleaning Validation Cognitive Biases in Strategy and Execution Fuzzy Logic, Risk Management, and Critical Thinking in Pharmaceuticals.  Integrate Risk…

July 1, 2022

MilliporeSigma to equip ex-BMS plant in strategic partnership with Lotte

by

Lotte Group has named MilliporeSigma as its preferred bioprocess vendor to support its burgeoning US-based CDMO business. In May, Lotte Corporation made its first steps into the US through the acquisition of Bristol-Myers Squibb’s facility in East Syracuse, New York, bagging a manufacturing contract with the former owners as part of the deal. Now, as the Korean firm looks to set up its US-based biologics contract development and manufacturing organization (CDMO) operations, it has signed a Memorandum of Understanding (MoU)…

July 1, 2022